Search results
Merck's KEYTRUDA shows survival benefit in gastric cancer trial By Investing.com
Investing.com· 11 hours agoMerck & Co., Inc., a leading pharmaceutical company, announced positive results from the Phase 3...
Merck raises 2024 profit forecast on strong sales of cancer drug Keytruda
Reuters via AOL· 7 days ago(Reuters) -Merck & Co on Thursday raised its annual profit and revenue forecast on the back of...
Merck (MRK) Q1 Earnings Top, Cancer Drug Keytruda Boosts Sales
Zacks· 7 days agoFree Report) reported adjusted earnings of $2.07 per share for first-quarter 2024, beating the Zacks Consensus Estimate of $1.94. Earnings rose 48% year over year on a reported basis and 54% ...
Merck Stock Climbs After Higher-Than-Expected Sales of Cancer Drug Keytruda
The Wall Street Journal· 7 days agoShares of U.S. drugmaker Merck are up nearly 4% in recent trading after the company said its...
Merck and Bristol-Myers Squibb are bracing to lose their most lucrative patents
Quartz· 6 days agoBoth companies reported quarterly earning Thursday, providing insights into how the drug...
Merck Stock Gains On Its Blockbuster Cancer Drug Keytruda, Raises Annual Outlook
Benzinga via Yahoo Finance· 6 days agoOn Thursday, U.S. drug maker Merck & Co Inc (NYSE:MRK) reported first-quarter sales of $15.8...
Merck's Cancer Drug and Vaccine Sales Drive Better-Than-Expected Results
Investopedia· 7 days agoMerck (MRK) shares advanced in intraday trading Thursday after the pharmaceutical firm reported...
Merck beats earnings expectations, raises outlook on strong Keytruda and vaccine sales
CNBC· 7 days agoMerck on Thursday reported first-quarter revenue and adjusted earnings that topped expectations as...
Merck Stock Jumps After Dow Jones Stalwart Rides Its Cancer 'Star' To Another Quarterly Beat
Investor's Business Daily· 6 days agoMerck stock popped Thursday after the Dow Jones stalwart topped Wall Street's first-quarter views on...
Merck Beats on Earnings a Month After Major Drug Approval. The Stock Is Rising.
Barrons.com· 7 days agoFEATURE Sales of Merck ‘s blockbuster cancer drug Keytruda jumped 20% in the first quarter of the...